RSS   Newsletter   Contact   Advertise with us
Post Online Media

Alphatec Spine appoints Jeffrey G. Black as CFO

Jeffrey G. BlackAlphatec Spine, a medical device company, announced the hiring of Jeffrey G. Black as executive vice president and chief financial officer.

Mr. Black is a seasoned executive with over 25 years of experience in financial and operations management, including senior-level finance roles for six publicly-traded companies.

READ MORE Alphatec Spine appoints new senior vice president, global human resources

Mr. Black previously served as the Chief Financial Officer of Applied Proteomics, Inc., a company that develops novel, non-invasive diagnostics using a proteomics-based platform.

Before joining Applied Proteomics, he served as the Chief Financial Officer of AltheaDx, Inc., a molecular diagnostics company specializing in pharmacogenetic testing.

Prior to AltheaDx, Mr. Black served as Chief Financial Officer of Verenium Corporation (formerly Diversa Corporation), a Nasdaq-listed pioneer in the development and commercialization of high-performance enzymes for use in industrial processes.

During his nine-year tenure at Verenium/Diversa, he played a leadership role in more than $500 million of strategic, equity, and debt financing transactions, culminating in the sale of the company to BASF in 2013.

Mr. Black is a certified public accountant (inactive) and began his career with Ernst & Young LLP.

He currently serves on the Board of Directors of Cellana, Inc., a privately-held algae bioproducts company.


 LATEST MOVES FROM California 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy